Condensed Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Apr. 30, 2016	May. 02, 2015
Cash flows from operating activities:
Net income	$ 136,731	$ 164,307
Adjustments to reconcile net income to net cash provided by operating activities:
Excess tax benefits from stock-based compensation	(10,987)	(29,570)
Depreciation and amortization	45,839	40,247
Loss on disposal of property and equipment	437	1,241
Amortization of debt issuance costs and debt discount	8,704	5,224
Write-off of debt discount and debt issuance costs related to lenders that did not participate in refinancing	0	4,808
Provision (recovery) for doubtful accounts receivable and sales allowances	(1,083)	4,694
Non-cash stock-based compensation expense	48,833	40,157
Changes in assets and liabilities, net of acquisitions:
Accounts receivable	32,051	35,237
Inventories	(424)	3,008
Prepaid expenses and other assets	(1,882)	(25,702)
Deferred tax assets	(74)	503
Accounts payable	(5,127)	(6,160)
Accrued employee compensation	(21,136)	(39,997)
Deferred revenue	(11,715)	(9,149)
Other accrued liabilities	5,500	25,285
Restructuring liabilities	(1,035)	(1,866)
Net cash provided by operating activities	224,632	212,267
Cash flows from investing activities:
Purchases of non-marketable equity and debt investments	(2,000)	(150)
Purchases of property and equipment	(42,425)	(34,091)
Purchase of intangible assets	0	(7,750)
Net cash paid in connection with acquisitions	(8,061)	(95,278)
Proceeds from collection of note receivable	250	250
Net cash used in investing activities	(52,236)	(137,019)
Cash flows from financing activities:
Payment of principal related to senior secured notes	0	300,000
Payment of debt issuance costs	0	(1,661)
Payment of principal related to capital leases	(197)	(1,267)
Common stock repurchases	(180,848)	(208,244)
Proceeds from issuance of common stock	20,512	21,975
Payment of cash dividends to stockholders	(36,445)	(29,854)
Proceeds from convertible notes	0	565,656
Purchase of convertible note hedge	0	(86,135)
Proceeds from issuance of warrants	0	51,175
Excess tax benefits from stock-based compensation	10,987	29,570
Net cash provided by (used in) financing activities	(185,991)	41,215
Effect of exchange rate fluctuations on cash and cash equivalents	356	(4,668)
Net increase (decrease) in cash and cash equivalents	(13,239)	111,795
Cash and cash equivalents, beginning of period	1,440,882	1,255,017
Cash and cash equivalents, end of period	1,427,643	1,366,812
Supplemental disclosures of cash flow information:
Cash paid for interest	10,891	18,937
Cash paid for income taxes	31,712	23,599
Settlement of debt investment in relation to acquisition	$ 0	$ 150